#InCaseYouMissedIt: We recently achieved a landmark milestone with the completion of enrollment of last patient in our Phase 3 Pivotal TransportNPC™ trial of Niemann-Pick Type C1. https://bit.ly/45aUoZZ #NiemannPick
Congratulations to the Cyclo Therapeutics, Inc. team!
Congrats, Josh and Team!
We're headed to #SCDM next week, are you?! Come see us at booth #305 to discuss how SDC can help support your clinical trials! Lucas Warner Derek Luther #clinicaltrials #CRO #clinicaltrialtechnologysolutions
Southern Star Research guides you and your product through the complexities of running a clinical trial. Our people are leaders in their field and can help you accelerate your study and achieve optimal results. #CRO #ClinicalTrials #MedicalTrials #ClinicalResearch
Reliable access to temperature-controlled shipping and storage capabilities allows CGT clinical trials greater flexibility in selecting trial sites, as well as impacting timeliness. Explore this and other CGT clinical trial logistic considerations in the blog. https://hubs.ly/Q02Gf1zx0 #CGT #ClinicalLogistics #TemperatureControl #AdvancedTherapies #CellTherapies #GeneTherapies #Storage #Shipping
The #ClinicalDevelopment of #RareDisease treatments poses unique challenges. Learn why so many sponsors rely on Calyx’s broad experience and scientific/technical expertise for these and other complex #ClinicalTrials. https://lnkd.in/eq_8vZue #ChooseCalyx #MedicalImaging #IRT #RTSM #RareDiseaseDay
2024 is sure to be a year of progress in #clinicalresearch. Make sure your trial is part of this year’s innovations. Get the tailored support you need to take your research to new heights with PRC Clinical. https://ow.ly/2GNS50QnYwQ #clinicaltrials #CRO
Trialtrove recorded 4,295 industry-sponsored clinical trials from Phase I through Phase III/IV that either reached completed status or reported primary endpoints during 2023. This number is 10.7% higher than the 3,881 completed trials in 2022 and reflects a return to growth by this metric. Another 1,030 trials were reported as terminated in 2023, representing an 8.1% increase over 2022 terminations (953). Since 2020, the completed trials counts have alternated between annual decreases, in 2020 and 2022, and increased trial completions, in 2021 and 2023.
What a mess! With the pricing model of traditional CROs, we don’t even want to know how much extra they were unnecessarily charged. Here at Lindus we pride ourselves on our milestone-based pricing model, so there’s no surprise costs or risk of your trials running over-budget. Have a CRO horror story? Submit yours here: https://lnkd.in/eYQUTM6Y #clinicalresearch #cro #clinicaltrials
Positive Phase III trial results for a new ETRA
Click here for the full content: https://bit.ly/CT-792766 On October 12, a new #Gilead (Kite)-sponsored Ph1 trial (https://bit.ly/48UOiOV) investigating KITE-197, a novel asset with an undisclosed target, in r/r #LBCL patients was posted on CT.gov. Additionally, on October 16, a new AZ-sponsored Ph1/2 #ATHENA (https://bit.ly/3rSttD7) trial evaluating #AZD5851 (TGFβRIIDN armored #GPC3 CAR-T) in ≥2L GPC3 positive advanced / recurrent HCC was detected. Celltelligence discusses the potential targets of KITE-197 while evaluating the relevance of the new AZ-sponsored clinical trial and the competitive advantage of AZD5851 over other GPC3 CAR-Ts.
Supply Chain
1wBest of luck!